California legislation that would limit the cost of a 30-day supply of insulin to $35 has passed the state Senate. Senate Bill 90, sponsored by the American Diabetes Association and presented by Sen. Scott Wiener (D-San Francisco), was approved unanimously by the Senate May 22. The bill is now under consideration in the state’s Assembly….
Bill Limiting Insulin Cost to $35 Passes California Senate
May 30, 2023
admin
CaliforniaCalifornia senateinsulinNorthern CaliforniaRegional & State NewsRegional NewsSACRAMENTOSouthern CaliforniaState NewsUS
0 Comment
The Price of Prescription Drugs Expected to Fall for Retirees
By Sandra Block From Kiplinger’s Personal Finance If you’re enrolled in Medicare and spend a lot of money on prescription drugs, legislation enacted last summer could lower some of your expenses. The prescription-drug provisions in the 2022 Inflation Reduction Act will be phased in over seven years, but some take effect as early as this…
One-Time Procedure May Potentially End Insulin Dependency in Type 2 Diabetes Patients
As of 2019, the latest year for which data are available, more than 37 million people in the United States—or 11.3 percent of the country’s population—are living with diabetes, according to the U.S. Centers for Disease Control and Prevention. Among them, 8.5 million are adults who are undiagnosed or unaware that they have the condition….
Sen. Sanders Asks Insulin Manufacturers to Testify Before Senate HELP Panel
Senate Health, Education, Labor, and Pensions (HELP) Committee Chairman Bernie Sanders has called the executives of top insulin manufacturers to testify before his panel. In an April 21 statement, Sanders (I-Vt.) announced a May 10 hearing of the HELP panel, entitled “The Need to Make Insulin Affordable for All Americans.” He also announced that the…
California, Drugmaker Partner to Produce Affordable Insulin
March 19, 2023
admin
affordableBusiness & MarketsCaliforniaCompaniesinsulinNorthern CaliforniaRegional & State NewsSouthern CaliforniaState NewsUSUS News
0 Comment
DOWNEY, Calif.—The state of California and a generic drug manufacturer announced a 10-year partnership Saturday to produce affordable, state-branded insulin that they hope will rival longtime producers and push down prices for a medication used by millions of Americans. The product is not expected on store shelves until at least next year, and it was…
All You Need to Know About Diabetes: Early Signs, Causes, Mindsets, and Natural Remedies
Diabetes is a chronic, metabolic disease characterized by abnormally high blood sugar levels. High blood sugar levels can do serious damage to the eyes, kidneys, and other organs. This is why it is vital to seek treatment if you suspect you may have diabetes. It was estimated in 2019 that 37.3 million Americans—11.3 percent of…
Major Drugmaker to Drastically Reduce Insulin Prices in United States
March 15, 2023
admin
affordable insulinBusiness & MarketsCompaniesHealth & SafetyinsulinLifestyleSocial Issuestype 1 diabetestype 2 diabetesUSUS News
0 Comment
Drugmaker Novo Nordisk has announced that it will significantly reduce insulin prices in the United States beginning next year—a relief for Americans struggling with high prices. Denmark-based Novo Nordisk will lower U.S. prices of several pre-filled insulin pens and vials by up to 75 percent for people living with Type 1 and Type 2 diabetes,…
Biden Admin Anticipates Lower Vaccine Costs for Seniors
March 15, 2023
admin
bidencongresseconomyExecutive BranchHealth & SafetyInflation Reduction ActinsulinLifestyleMedicarePolicies & ImpactsPoliticsUSUS News
0 Comment
Biden administration officials are projecting that seniors on Medicare Part D will save hundreds of millions of dollars on vaccines because of the 2022 reconciliation bill, also known as the Inflation Reduction Act (IRA). Notably, the estimates don’t include COVID-19 vaccines, which fall under Medicare Part B. “The law makes many recommended vaccines free for…
Major Drugmaker to Cut Insulin Prices for Americans, Cap Out-of-Pocket Costs at $35
Eli Lilly and Co. announced on Wednesday that prices for the company’s most commonly prescribed insulins will be reduced by up to 70 percent later this year, a move praised by President Joe Biden, who urged other drugmakers to follow. In a statement published on Mar. 1, the largest U.S. manufacturer of insulin said that…
Paxton Launches Investigation Into Drugmakers Over Inflated Insulin Costs
Texas Attorney General Ken Paxton has launched an investigation into drug manufacturers, wholesalers, and pharmacy benefit managers (PBMs) over potential legal violations related to inflated costs of insulin, a life-saving drug relied upon by millions of diabetics. Insulin prices are exponentially higher in the United States than in other developed countries, but over the last…
-
Recent Posts
-
Archives
- May 2025
- April 2025
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- September 2013
- July 2013
- March 2013
- January 2013
- December 2012
- November 2012
- December 1
-
Meta